News Detail

Mumbai, 2 March 2025: Glenmark Pharmaceuticals Ltd. is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention deficit hyperactivity disorder in the US market, according to the Food and Drug Administration.
Glenmark Pharmaceuticals......
View Details
Source : PTI
Glenmark Pharmaceuticals Ltd
deficit hyperactivity disorder
Food and Drug Administration
Atomoxetine Capsules
Related News
- DCC recommends upgradation of guidelines related to samples of spurious, NSQ drugs (03-03-2025)
- Tough to get details about drug manufacturers from other States: Kerala Drugs Control dept. (03-03-2025)
- CDSCO centralises GMP issuance and verification with new online portal (03-03-2025)
- Sirohi: Innocent died due to wrong injection, police arrested the quack; clinic seized (02-03-2025)
- Five women slip into delirium; anaesthesia drug reaction suspected (02-03-2025)
- CDSCO revamps NOC process for unapproved drug exports to boost efficiency & reduce manpower pressure (02-03-2025)
- DCA Telangana cracks down on illegal drug sales and misleading ads (02-03-2025)
- DCGI asks SLAs to strengthen state drug testing laboratories (02-03-2025)
- 'Fake doctor' gets govt job, treats patients for a year, now faces FIR (02-03-2025)
- Lucknow police bust gang selling 'Bijli ka Tel' to 'cure' joint pain (02-03-2025)